Lexaria Bioscience (LEXX) Operating Margin Growth (1y) (2018 - 2026)
Lexaria Bioscience (LEXX) Operating Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 7,666.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1,238.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2,002.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3,558.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 29,091.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -1,651.00 |
| 10 | Lexaria Bioscience | 10.15 Mn | 6.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -567,847.00 |
| Aug 31, 2025 | 107,752.00 |
| May 31, 2025 | -8,051.00 |
| Feb 28, 2025 | -112,035.00 |
| Nov 30, 2024 | -70,994.00 |
| Aug 31, 2024 | 100,150.00 |
| May 31, 2024 | 101,473.00 |
| Feb 29, 2024 | 614,917.00 |
| Nov 30, 2023 | 98,170.00 |
| Aug 31, 2023 | -295,074.00 |
| May 31, 2023 | -66,444.00 |
| Feb 28, 2023 | -188,336.00 |
| Nov 30, 2022 | 1.27 Mn |
| Aug 31, 2022 | 352,584.00 |
| May 31, 2022 | -116,743.00 |
| Feb 28, 2022 | -415,125.00 |
| Nov 30, 2021 | -1.45 Mn |
| Aug 31, 2021 | -285,100.00 |
| May 31, 2021 | 261,413.00 |
| Feb 28, 2021 | 225,219.00 |